Literature DB >> 12711007

Identification of a Vitamin D response element in the human insulin receptor gene promoter.

Begoña Maestro1, Norma Dávila, M Carmen Carranza, Consuelo Calle.   

Abstract

The present study was designed to explore the possible presence and location of Vitamin D response elements (VDREs) in the human insulin receptor (hIR) gene promoter. To this end, the -1819 to -271 bp fragment of the hIR promoter (wild type promoter) and progressive 5' deletions of this promoter (up to -1473 and -876 bp) were linked to the luciferase pGL2-basic vector to construct the reported plasmids: phIR (-1819)-GL2, phIR(-1473)-GL2 and phIR(-876)-GL2, respectively. U-937 cells were transiently transfected with these plasmids, and then the cells were either untreated or treated for 24h with 10(-8) M 1,25-dihydroxyvitamin D(3) (1,25D(3)). Luciferase determinations revealed that, while the activity of the wild promoter was increased 1.6-fold by the hormone, the activities of progressive 5' deletions of this promoter were enhanced 1.7-, and 1.6-fold, respectively. Thus, the region extending from -876 to -271bp of the hIR promoter, appears to contain VDREs, and to be sufficient for induction by 1,25D(3). In order to identify these potential VDREs, we performed a computer search of candidate sequences by homology with a consensus VDRE sequence. This search yielded a sequence located between -761 and -732 bp (5'CGTCGGGCCTGTGGGGCGCCTCCGGGGGTC3'), which includes an overlapping AP-2 like sequence, as a good candidate. Electrophoretic mobility shift assays revealed that the Vitamin D receptor (VDR) specifically recognized this sequence, since a VDR-DNA complex was able to compete with the unlabeled probe and was cleared by the specific anti-VDR antibody 9A7. These data represent the first identification of a VDRE in the hIR gene promoter.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711007     DOI: 10.1016/s0960-0760(03)00032-3

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  88 in total

Review 1.  Is dietary fat, vitamin D, or folate associated with pancreatic cancer?

Authors:  G V Sanchez; S J Weinstein; R Z Stolzenberg-Solomon
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Vitamin D deficiency in obese children and its relationship to glucose homeostasis.

Authors:  Micah L Olson; Naim M Maalouf; Jon D Oden; Perrin C White; Michele R Hutchison
Journal:  J Clin Endocrinol Metab       Date:  2011-11-09       Impact factor: 5.958

Review 3.  Steroid Hormone Vitamin D: Implications for Cardiovascular Disease.

Authors:  Linda L Demer; Jeffrey J Hsu; Yin Tintut
Journal:  Circ Res       Date:  2018-05-25       Impact factor: 17.367

4.  Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells.

Authors:  Vandanajay Bhatia; Miriam Falzon
Journal:  Cancer Lett       Date:  2015-04-03       Impact factor: 8.679

5.  Effect of high-dose vitamin D supplementation on cardiometabolic risk factors in subjects with metabolic syndrome: a randomized controlled double-blind clinical trial.

Authors:  S Salekzamani; H Mehralizadeh; A Ghezel; Y Salekzamani; M A Jafarabadi; A S Bavil; B P Gargari
Journal:  J Endocrinol Invest       Date:  2016-07-11       Impact factor: 4.256

Review 6.  Vitamin D and diabetes.

Authors:  Joanna Mitri; Anastassios G Pittas
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

Review 7.  Vitamin D insufficiency and insulin resistance in obese adolescents.

Authors:  Catherine A Peterson; Aneesh K Tosh; Anthony M Belenchia
Journal:  Ther Adv Endocrinol Metab       Date:  2014-12       Impact factor: 3.565

8.  Vitamin D deficiency, insulin resistance, serum adipokine, and leptin levels in peritoneal dialysis patients.

Authors:  Ozkan Ulutas; Hulya Taskapan; Mehmet Cagatay Taskapan; Ismail Temel
Journal:  Int Urol Nephrol       Date:  2012-10-12       Impact factor: 2.370

9.  Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Authors:  Rachael Z Stolzenberg-Solomon; Eric J Jacobs; Alan A Arslan; Dai Qi; Alpa V Patel; Kathy J Helzlsouer; Stephanie J Weinstein; Marjorie L McCullough; Mark P Purdue; Xiao-Ou Shu; Kirk Snyder; Jarmo Virtamo; Lynn R Wilkins; Kai Yu; Anne Zeleniuch-Jacquotte; Wei Zheng; Demetrius Albanes; Qiuyin Cai; Chinonye Harvey; Richard Hayes; Sandra Clipp; Ronald L Horst; Lonn Irish; Karen Koenig; Loic Le Marchand; Laurence N Kolonel
Journal:  Am J Epidemiol       Date:  2010-06-18       Impact factor: 4.897

10.  Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis.

Authors:  Jessica A Alvarez; Ambika Ashraf
Journal:  Int J Endocrinol       Date:  2010       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.